Discovery Engine

Saxenda (liraglutide) is a once-daily GLP-1 receptor agonist originally developed for type 2 diabetes but later approved for chronic weight management...

Rybelsus is the first oral formulation of semaglutide, FDA-approved for type 2 diabetes management. While not officially indicated for weight loss, it...

Ozempic (semaglutide) is a once-weekly injectable medication from Novo Nordisk, FDA-approved for type 2 diabetes management. By mimicking the GLP-1 ho...

Mounjaro (tirzepatide) is an FDA-approved injectable medication developed by Eli Lilly, originally indicated for type 2 diabetes management. As a dual...

A clinician-led, telehealth metabolic health program focused on reversal of type 2 diabetes and sustainable weight loss through keto-style nutrition c...

Glucagon-like peptide-1 receptor agonists (GLP-1 drugs) have emerged as one of the most significant advances in modern medicine, reshaping how clinici...

In recent years, glucagon-like peptide-1 receptor agonists (GLP-1 drugs) have gained widespread recognition for their ability to manage type 2 diabete...

At a GlanceBoth Wegovy and Ozempic share the same active ingredient: semaglutide.Wegovy is FDA-approved for weight loss, while Ozempic is approved for...

Internal Medicine, Endocrinology, Diabetes & Metabolism in 1831 Wilshire Boulevard, Suite A Santa Monica, CA 90403

Internal Medicine, Endocrinology, Diabetes & Metabolism in 425 E. 61st St., 8-11th Floor, New York, NY 10065